Skip to main content

Table 6 Comparison of intrinsic subtypes distribution in different populations

From: The relevance of the intrinsic subtype to the clinicopathological features and biomarkers in Japanese breast cancer patients

Reference

Country

All patients (%)

ER/PR + HER2-

ER/PR + HER2+

HER2 type

Basel-like

Unclassified

Our research

Japan

471 (100)

306 (65.0)

41 (8.7)

59 (12.5)

37 (7.9)

28 (5.9)

Shibuta et al . [[6]]

Japan

4,266 (100)

3,046 (71)

321 (8)

398 (9)

501 (12)

Carey et al . [[2]]

US

496 (100)

255 (51.4)

77 (15.5)

33 (6.7)

100 (20.1)

31 (6.3)

African American

196 (100)

93 (47.4)

25 (12.8)

16 (8.2)

52 (26.5)

10 (5.1)

Non-African American

300 (100)

162 (54)

52 (17.3)

17 (5.7)

48 (16)

21 (7)

Tamimi et al . [[3]]

US

2,249 (100)

1,650 (73)

116 (5)

128 (6)

245 (11)

110 (5)